Metallis Resources Inc. Advances Its Antimony Program Metallis Resources Inc. (TSXV: MTS, OTCQB: MTLFF) is excited to announce the commencement of its second phase of exploration at the Greyhound Property, furthering its quest in the antimony sector. Following a successful initial field exploration program last summer, the company is diving deeper into this promising...
Continue Reading
Aspo Group Unveils Comprehensive Annual Report Insights Aspo Group has recently shared its Annual Report for the year 2024, highlighting significant achievements and outlining strategic directions for the future. This comprehensive document is now available on the company’s website, providing stakeholders with an in-depth look at the group’s performance and...
Continue Reading
Nvidia's Strategic Move in AI Chip Sales to China The recent decision to allow Nvidia (NASDAQ: NVDA) to sell its H200 artificial intelligence chip to China has sparked renewed discussions around the intersection of technology trade and national security. This moment is pivotal, as it reflects both market dynamics and geopolitical tensions that investors must navigate. The...
Continue Reading
Pasinex Resources Limited Financial Results Announcement Toronto, Nov. 21, 2025 — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) has released significant financial results for the three and nine months ended September 30, 2025, along with a corporate update that sheds light on the current operations and future prospects of the company. Financial Performance Overview In...
Continue Reading
Here comes a curveball from the great white north! Canada’s Drug Agency has thrown its weight behind BioArctic and Eisai's Leqembi, recommending public reimbursement for those battling mild cognitive impairment or mild dementia due to Alzheimer's. This is more than just another tick on a list—it's a potential gamechanger for patients. What's the Big Deal? The...
Continue Reading